Scisparc – CFN Media

Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio

Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 — Clearmind Medicine…

Ryan Allway
August 1, 2023

Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and Metabolic Syndrome

The treatment combines Clearmind’s MEAI, a novel proprietary psychedelic treatment for various addictions, and…

Ryan Allway
June 16, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Stallion Uranium Advancing Key Targets with HeliSam Survey

VANCOUVER, British Columbia, Oct. 03, 2024 (GLOBE NEWSWIRE) — Stallion Uranium…

Ryan Allway
October 3, 2024

Legislation, Lawsuits Pushing Plastic Recycling Technology Forward

Sometimes, inadequate systems and processes become so ingrained that a major catalyst…

Ryan Allway
September 25, 2024

Lithium Offtake Agreements, Mergers Offer Opportunities

The lithium market has had a bit of a rocky year, with…

Robin Lefferts
September 24, 2024

Healthcare Stocks

Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis

Toronto, Ontario–(Newsfile Corp. – September 24, 2024) – Cardiol…

Ryan Allway
September 24, 2024